Ticker
ABSI

Price
4.38
Stock movement up
+0.13 (3.06%)
Company name
Absci Corp
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
406.69M
Ent value
235.65M
Price/Sales
280.09
Price/Book
1.19
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-80.64%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2022-08-25

DIVIDENDS

ABSI does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales280.09
Price to Book1.19
EV to Sales162.29

FINANCIALS

Per share

Loading...
Per share data
Current share count92.85M
EPS (TTM)-1.00
FCF per share (TTM)-1.26

Income statement

Loading...
Income statement data
Revenue (TTM)1.45M
Gross profit (TTM)-4.38M
Operating income (TTM)-92.89M
Net income (TTM)-90.00M
EPS (TTM)-1.00
EPS (1y forward)-1.24

Margins

Loading...
Margins data
Gross margin (TTM)-301.86%
Operating margin (TTM)-6397.59%
Profit margin (TTM)-6198.21%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash226.00M
Net receivables350.00K
Total current assets255.96M
Goodwill21.34M
Intangible assets54.15M
Property, plant and equipment0.00
Total assets395.46M
Accounts payable6.74M
Short/Current long term debt18.21M
Total current liabilities41.88M
Total liabilities54.96M
Shareholder's equity340.50M
Net tangible assets286.35M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-74.46M
Capital expenditures (TTM)38.54M
Free cash flow (TTM)-113.00M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-26.43%
Return on Assets-22.76%
Return on Invested Capital-25.88%
Cash Return on Invested Capital-32.50%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open4.25
Daily high4.50
Daily low4.25
Daily Volume592K
All-time high30.29
1y analyst estimate15.50
Beta-
EPS (TTM)-1.00
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ABSIS&P500
Current price drop from All-time high-85.54%-13.41%
Highest price drop-89.67%-56.47%
Date of highest drop12 Jul 20229 Mar 2009
Avg drop from high-68.24%-11.38%
Avg time to new high46 days12 days
Max time to new high268 days1805 days
COMPANY DETAILS
ABSI (Absci Corp) company logo
Marketcap
406.69M
Marketcap category
Small-cap
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Employees
211
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
VANCOUVER, Wash. and NEW YORK, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand th...
September 1, 2022
VANCOUVER, Wash. and NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the...
August 24, 2022
Absci reported a net loss of $28.7 million a day after announcing a "strategic reorganization."
August 15, 2022
Absci Corporation (ABSI) delivered earnings and revenue surprises of 0% and 38.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
August 11, 2022
Exceeded annual Active Program guidance with ten programs signed year-to-date Executed strategic reorganization to extend cash runway into late-2025 VANCOUVER, Wash. and NEW YORK, Aug. 11, 2022 (GLOBE...
August 11, 2022
Biotech firm Absci announced an unspecified number of layoffs Tuesday, blaming "macroeconomic conditions" and the need to streamline operations. "The macro-economic conditions of the last few months ...
August 10, 2022
Absci, Axcella Health, Freeline Therapeutics Holdings, DICE Therapeutics and Pliant Therapeutics are part of Zacks top Analyst Blog.
August 10, 2022
Risk and reward are the yin and yang of stock trading, the two opposite but essential ingredients in every market success. And there are no stocks that better embody both sides – the risk factors and ...
August 2, 2022
VANCOUVER, Wash. and NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the...
August 1, 2022
Birch Biosciences is bringing synthetic biology to plastic recycling to create a true circular plastic economy.
July 26, 2022
Next page